Pfizer COVID vaccine clears Japan panel for use with young children Ruchika Sharma7 Oct 2022 3:30 PM ISTTokyo: A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old.Japan...
Pfizer, BioNTech complete submission to EMA for Omicron BA.4/BA.5-Adapted Bivalent vaccine booster in children aged 5 Through 11 years Ruchika Sharma2 Oct 2022 3:45 PM ISTCOMIRNATY, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer India, Father Muller Research collaborate to strengthen evidence generation in cancer, cardiovascular disease Ruchika Sharma27 Sept 2022 2:30 PM ISTThe Father Muller Research will be COE for placing various RWE studies, capability-building workshops, and fellowship programs in rare disease area to...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster for Children aged 5 through 11 years Ruchika Sharma27 Sept 2022 11:15 AM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
CEO of Pfizer tests COVID positive again Ruchika Sharma26 Sept 2022 1:45 PM ISTThe chief executive said he has not yet taken the new bivalent booster.
Haleon believes it is not liable for any potential Zantac liabilities Ruchika Sharma20 Sept 2022 3:30 PM ISTHaleon has repeatedly said that it never marketed Zantac in any form in the United States, either as Haleon or as GSK Consumer Healthcare.
Pfizer COVID vaccine approved for children as young as six months in Brazil Ruchika Sharma19 Sept 2022 1:30 PM ISTRio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between...
Pfizer- BioNTech get positive CHMP opinion for conversion of COMIRNATY conditional marketing nod to full marketing nod in EU Ruchika Sharma18 Sept 2022 9:00 AM ISTNew Delhi: Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Pfizer begins Phase 3 clinical trial of mRNA-based Influenza vaccine Ruchika Sharma15 Sept 2022 11:00 AM ISTNew York: Pfizer Inc. has announced that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the...
Pfizer, BioNTech Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster get CHMP nod Ruchika Sharma14 Sept 2022 11:37 AM ISTIf an authorization is granted, the Pfizer-BioNTech bivalent Omicron BA.4/BA.5 COVID-19 vaccine will be available within the coming days to all 27 EU...
Pfizer COVID vaccine approved for kids under 5 in Canada MD Bureau11 Sept 2022 3:46 PM ISTIt's the second vaccine approved for that age group after Health Canada approved Moderna's Spikevax in July.
Zenara Pharma launches generic of Pfizer Paxlovid at Rs 5,200 per box in India Roshni Dhar11 Sept 2022 2:33 PM ISTHyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that the company has launched Nirmatrelvir...
